Our findings are similar to data published by Lim et al. (2015), who analyzed medulloblastoma cells treated with GANT61 for 24 h and reported significantly inhibited gene and protein expression of GLI1 and GLI2, as well as reduced mRNA levels of the oncogene BCL2 at all tested concentrations (10, 20, and 40 μM). The gene discussed is GLI1; the disease is medulloblastoma.